Macrophage migration inhibitory factor: a potential biomarker for chronic low back pain in patients with Modic changes
Background Low back pain (LBP) is a leading cause of disability worldwide, but the aetiology remains poorly understood. Finding relevant biomarkers may lead to better understanding of disease mechanisms. Patients with vertebral endplate bone marrow lesions visualised on MRI as Modic changes (MCs) ha...
Main Authors: | Are Hugo Pripp, Kjersti Storheim, Lars Christian Haugli Bråten, Monica Wigemyr, Maria Dehli Vigeland, John Anker Zwart, Linda Margareth Pedersen, Elisabeth Gjefsen, Kristina Gervin, Guro Goll, Hans Christian D Aass, Elina Schistad, Kaja Kristine Selmer |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2021-08-01
|
Series: | RMD Open |
Online Access: | https://rmdopen.bmj.com/content/7/2/e001726.full |
Similar Items
-
Long-Term Use of Amoxicillin Is Associated with Changes in Gene Expression and DNA Methylation in Patients with Low Back Pain and Modic Changes
by: Maria Dehli Vigeland, et al.
Published: (2023-07-01) -
Cytokine Patterns as Predictors of Antibiotic Treatment Effect in Chronic Low Back Pain with Modic Changes: Subgroup Analyses of a Randomized Trial (AIM Study)
by: Bråten LCH, et al.
Published: (2023-05-01) -
The effect of infliximab in patients with chronic low back pain and Modic changes (the BackToBasic study): study protocol of a randomized, double blind, placebo-controlled, multicenter trial
by: Elisabeth Gjefsen, et al.
Published: (2020-10-01) -
Association of Modic change types and their short tau inversion recovery signals with clinical characteristics- a cross sectional study of chronic low back pain patients in the AIM-study
by: Lars Christian Haugli Bråten, et al.
Published: (2020-06-01) -
Clinical effect modifiers of antibiotic treatment in patients with chronic low back pain and Modic changes - secondary analyses of a randomised, placebo-controlled trial (the AIM study)
by: Lars Christian Haugli Bråten, et al.
Published: (2020-07-01)